Supplemental Table 2 from Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients

Supplemental Table 2 from Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients

<p>Supplemental Table 2 shows the complete list of variants detected and their source (tumor, germline, CH) in the liquid biopsy cohort.</p>

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Daniel Magee (21631982) (author)
Rannpháirtithe:	Valeriy Domenyuk (21631985) (author), Jim Abraham (18472789) (author), Nieves Perdigones Borderias (21631988) (author), Jeff Swensen (21631991) (author), Praveena Solipuram (21631994) (author), Adanma Ayanambakkam (21631997) (author), Raja Mehdi (21632000) (author), Jagathi Challagalla (21632003) (author), Elisabeth Heath (19450801) (author), Megan Landsverk (21632006) (author), Magdalena Jurkiewicz (21632009) (author), Brian Shimkus (21632012) (author), Ian Pinto (21632015) (author), Daniel Patterson (21632018) (author), David Hsiehchen (15561361) (author), Supriya Koya (21632021) (author), Bradley Somer (21632024) (author), Michel Velez (21632027) (author), Anthony F. Shields (15029154) (author), Jennifer Cultrera (21632030) (author), Jennifer R. Ribeiro (19801844) (author), Robert Hahn-Lowry (21632033) (author), George W. Sledge (15561344) (author), Matthew Oberley (20018063) (author), Milan Radovich (15045056) (author), David Spetzler (18472792) (author)
Foilsithe / Cruthaithe:	2025
Ábhair:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Liquid Biopsy Precision Medicine
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Supplementary Tables from Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
de réir: Zachariah H. Foda (15124605)
Foilsithe / Cruthaithe: (2025)

Figure 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Figure 2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Figure 3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Figure 4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Figure 5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Figure 6 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Table 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Figure S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
de réir: Ruiliang Wang (17333340)
Foilsithe / Cruthaithe: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
de réir: Lavanya Sivapalan (15314248)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
de réir: Navonil De Sarkar (15030509)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
de réir: Navonil De Sarkar (15030509)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
de réir: Navonil De Sarkar (15030509)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
de réir: Navonil De Sarkar (15030509)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S5 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
de réir: Navonil De Sarkar (15030509)
Foilsithe / Cruthaithe: (2025)

Data Sheet 2_Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNA.docx
de réir: Ying Tian (180972)
Foilsithe / Cruthaithe: (2025)

Data Sheet 1_Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNA.docx
de réir: Ying Tian (180972)
Foilsithe / Cruthaithe: (2025)

Supplemental Table 1 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
de réir: Morten Lapin (15056728)
Foilsithe / Cruthaithe: (2025)

Supplemental Table 2 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
de réir: Morten Lapin (15056728)
Foilsithe / Cruthaithe: (2025)

Supplemental Table 3 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
de réir: Morten Lapin (15056728)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
de réir: Sofie H. Tolmeijer (15313251)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
de réir: Sofie H. Tolmeijer (15313251)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
de réir: Sofie H. Tolmeijer (15313251)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer
de réir: Edward S. Sim (15121025)
Foilsithe / Cruthaithe: (2025)

Table 1_Therapeutic and diagnostic implications of exosomes as natural nanoparticles: a new paradigm in brain cancer disease management.docx
de réir: Shanid Mohiyuddin (4438060)
Foilsithe / Cruthaithe: (2025)

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
de réir: Andrew A. Davis (15030032)
Foilsithe / Cruthaithe: (2025)

Supplementary file 1_MiRNA sequencing of platelet and exosome revealed platelet miR-199b-3p as a potential biomarker in lung adenocarcinoma.docx
de réir: Xiaoxia Wen (462854)
Foilsithe / Cruthaithe: (2025)

Figure 1 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
de réir: Eshwari Dathathri (22071316)
Foilsithe / Cruthaithe: (2025)

Figure 2 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
de réir: Eshwari Dathathri (22071316)
Foilsithe / Cruthaithe: (2025)

Figure 3 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
de réir: Eshwari Dathathri (22071316)
Foilsithe / Cruthaithe: (2025)

Figure 4 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
de réir: Eshwari Dathathri (22071316)
Foilsithe / Cruthaithe: (2025)

Figure 5 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
de réir: Eshwari Dathathri (22071316)
Foilsithe / Cruthaithe: (2025)